Steven Kussick - Pheno Path Laboratories

PhenoPath, a Quest Diagnostics company based in Seattle, WA, offers specialized diagnostic services for cancer patients, providing accurate and reliable diagnoses to guide treatment decisions. With a team of expert pathologists and medical professionals, PhenoPath specializes in gastrointestinal, hepatobiliary, genitourinary, hematology, and molecular pathology. Known for their collaborative approach and extensive experience in interpreting PD-L1 and flow cytometry 10-color, PhenoPath is dedicated to advancing cancer diagnostics through peer-reviewed expertise, specialized insights, and the development of innovative diagnostic solutions for biomarker discovery and drug development.Generated from the website

Stemgenics is a Seattle-based company that specializes in disruptive nanotherapeutics technology, offering a multi-specific platform for therapeutic drug development. Their patent-protected non-integrating nanoparticles, known as NIMFA-NP, are designed to deliver a wide range of bioactive molecules into cells, tissues, organs, and organisms, making them highly effective in regenerative medicine, oncology, and vaccine development. With a focus on regenerative medicine, Stemgenics' customizable NIMFA-NP can be functionalized with different bioactive molecules to target specific intracellular processes, allowing for tissue rejuvenation, organ revitalization, and lifespan extension. Additionally, their nanotechnology, protected by numerous patents, enables in vivo direct reprogramming of cells for liver and heart regeneration, as well as the treatment of neurodegenerative diseases and oncology through gene-specific mRNA and siRNA therapeutics.Generated from the website